The global closed system transfer device market size was USD 1.30 billion in 2023, estimated at USD 1.43 billion in 2024 and is anticipated to reach around USD 3.66 billion by 2034, expanding at a CAGR of 9.84% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
5.1. Covid-19: Regenerative Medicine Industry Impact
5.2. Regenerative Medicine Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Regenerative Medicine Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Regenerative Medicine Market Players to deal with Covid-19 Pandemic Scenario
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing prevalence of cancer
6.1.1.2. Growing need for regulatory compliance for safe handling of harmful drugs
6.1.2. Market Restraints
6.1.2.1. High cost systems
6.1.3. Market Opportunities
6.1.3.1. Rising adoption of closed system transfer devices for transferring hazardous drugs
6.1.3.2. Increasing use of CSTDs in emerging markets
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Regenerative Medicine Market Revenue by Market Players
7.1.1.2. Regenerative Medicine Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
8.1. Regenerative Medicine Market, by Product, 2024-2034
8.1.1. Needleless Systems
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Membrane-to-Membrane Systems
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Regenerative Medicine Market, by Application, 2024-2034
9.1.1. Color-To-Color Alignment Systems
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Push-To-Turn Systems
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Click-To-Lock Systems
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Luer-Lock Systems
9.1.4.1. Market Revenue and Forecast (2021-2034)
10.1. Regenerative Medicine Market, by Application, 2024-2034
10.1.1. Syringe Safety Devices
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Vial Access Devices
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Accessories
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Bag/Line Access Devices
10.1.4.1. Market Revenue and Forecast (2021-2034)
11.1. Regenerative Medicine Market, by Application, 2024-2034
11.1.1. Clinics & Oncology Centers
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Hospitals
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Others
11.1.3.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue Forecast by Type (2021-2034)
12.1.2. Market Revenue Forecast by Closing Mechanism (2021-2034)
12.1.3. Market Revenue Forecast by Component (2021-2034)
12.1.4. Market Revenue Forecast by End User (2021-2034)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2021-2034)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2021-2034)
12.2. Europe
12.2.1. Market Revenue Forecast by Type (2021-2034)
12.2.2. Market Revenue Forecast by Closing Mechanism (2021-2034)
12.2.3. Market Revenue Forecast by Component (2021-2034)
12.2.4. Market Revenue Forecast by End User (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2021-2034)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2021-2034)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Type (2021-2034)
12.3.2. Market Revenue Forecast by Closing Mechanism (2021-2034)
12.3.3. Market Revenue Forecast by Component (2021-2034)
12.3.4. Market Revenue Forecast by End User (2021-2034)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2021-2034)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2021-2034)
12.4. LATAM
12.4.1. Market Revenue Forecast by Type (2021-2034)
12.4.2. Market Revenue Forecast by Closing Mechanism (2021-2034)
12.4.3. Market Revenue Forecast by Component (2021-2034)
12.4.4. Market Revenue Forecast by End User (2021-2034)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2021-2034)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2021-2034)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Type (2021-2034)
12.5.2. Market Revenue Forecast by Closing Mechanism (2021-2034)
12.5.3. Market Revenue Forecast by Component (2021-2034)
12.5.4. Market Revenue Forecast by End User (2021-2034)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2021-2034)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2021-2034)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2021-2034)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2021-2034)
13.1. Baxter International Inc.
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. ProductPortfolio Analysis
13.1.2.1. ProductDetails, Specification, Application
13.1.3. Revenue, Price, and Gross Margin
13.1.4. Recent Developments and Strategies
13.2. Becton, Dickinson, and Company
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin
13.2.4. Recent Developments and Strategies
13.3. CodanMedizinischeGeräte GmbH & Co Kg
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin
13.3.4. Recent Developments and Strategies
13.4. ICU Medical, Inc.
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin
13.4.4. Recent Developments and Strategies
13.5. Yukon Medical
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin
13.5.4. Recent Developments and Strategies
13.6. B. Braun Melsungen
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin
13.6.4. Recent Developments and Strategies
13.7. Equashield
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin
13.7.4. Recent Developments and Strategies
13.8. Teva Pharmaceutical Industries Ltd.
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin
13.8.4. Recent Developments and Strategies
13.9. Victus, Inc.
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin
13.9.4. Recent Developments and Strategies
13.10. Corvida Medical
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin
13.10.4. Recent Developments and Strategies
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample